<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"	
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:media="http://search.yahoo.com/mrss/"
	>
<channel>
	<title>Nurses/NP/PA &#187; The Doctor&#039;s Channel</title>
	<atom:link href="http://www.thedoctorschannel.com/channels/nurses/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.thedoctorschannel.com</link>
	<description>Internet TV for Doctors</description>
	<lastBuildDate>Wed, 16 May 2012 23:34:19 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
			<item>
		<title>ACE inhibitor treated hypertension linked to reduced all-cause mortality</title>
		<link>http://www.thedoctorschannel.com/view/ace-inhibitor-treated-hypertension-linked-to-reduced-all-cause-mortality/</link>
		<pubDate>Wed, 16 May 2012 15:39:22 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Home Page Featured]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[ACE inhibitor]]></category>
		<category><![CDATA[angiotensin]]></category>
		<category><![CDATA[hypertension]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31830</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – All-cause mortality rates among hypertensive patients treated with an angiotensin-converting enzyme inhibitor are 10% lower than in those whose treatment does not include an ACE inhibitor, according to the results of a meta-analysis reported in the European Heart Journal online April 17. “In view of the high prevalence of hypertension -]]></description>
		
			<media:content duration="1:23" medium="video">
		<media:title><![CDATA[ACE inhibitor treated hypertension linked to reduced all-cause mortality]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – All-cause mortality rates among hypertensive patients treated with an angiotensin-converting enzyme inhibitor are 10% lower than in those whose treatment does not include an ACE inhibitor, according to the results of a meta-analysis reported in the European Heart Journal online April 17. “In view of the high prevalence of hypertension -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/ace-inhibitor-treated-hypertension-linked-to-reduced-all-cause-mortality/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120516epid004.jpg"/>
	<media:keywords><![CDATA[ACE inhibitor,angiotensin,hypertension]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Comprehensive care program does not prevent COPD hospitalizations</title>
		<link>http://www.thedoctorschannel.com/view/comprehensive-care-program-does-not-prevent-copd-hospitalizations/</link>
		<pubDate>Wed, 16 May 2012 15:30:24 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Home Page Featured]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Pulmonary Medicine]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[SHM 2011 Conference Coverage]]></category>
		<category><![CDATA[COPD]]></category>
		<category><![CDATA[education]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31828</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – A program of patient education and planning aimed at treating exacerbations of chronic obstructive pulmonary disease early and reducing rates of hospitalization was not effective in a randomized controlled trial. In fact, the trial was stopped when it was seen that the intervention was associated with a threefold increase in -]]></description>
		
			<media:content duration="1:38" medium="video">
		<media:title><![CDATA[Comprehensive care program does not prevent COPD hospitalizations]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – A program of patient education and planning aimed at treating exacerbations of chronic obstructive pulmonary disease early and reducing rates of hospitalization was not effective in a randomized controlled trial. In fact, the trial was stopped when it was seen that the intervention was associated with a threefold increase in -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/comprehensive-care-program-does-not-prevent-copd-hospitalizations/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120516clin002.jpg"/>
	<media:keywords><![CDATA[COPD,education]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Sumatriptan-naproxen combo effective for adolescent migraine</title>
		<link>http://www.thedoctorschannel.com/view/sumatriptan-naproxen-combo-effective-for-adolescent-migraine/</link>
		<pubDate>Wed, 16 May 2012 15:16:39 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Home Page Featured]]></category>
		<category><![CDATA[Neurology & Neurosurgery]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Pharmacists]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[migraine]]></category>
		<category><![CDATA[naproxen]]></category>
		<category><![CDATA[sumatriptan]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31826</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Based on the results of a randomized, double-blind trial, more adolescents with acute migraine become pain-free within 2 hours after taking a combination of sumatriptan and naproxen sodium compared to placebo, according to a report in the June issue of Pediatrics. “This study constitutes the first large-scale, placebo-controlled evidence for -]]></description>
		
			<media:content duration="1:30" medium="video">
		<media:title><![CDATA[Sumatriptan-naproxen combo effective for adolescent migraine]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Based on the results of a randomized, double-blind trial, more adolescents with acute migraine become pain-free within 2 hours after taking a combination of sumatriptan and naproxen sodium compared to placebo, according to a report in the June issue of Pediatrics. “This study constitutes the first large-scale, placebo-controlled evidence for -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/sumatriptan-naproxen-combo-effective-for-adolescent-migraine/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120516clin001.jpg"/>
	<media:keywords><![CDATA[migraine,naproxen,sumatriptan]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Aspirin use doesn&#8217;t curb peptic ulcer healing</title>
		<link>http://www.thedoctorschannel.com/view/aspirin-use-doesnt-curb-peptic-ulcer-healing/</link>
		<pubDate>Tue, 15 May 2012 18:56:57 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Gastroenterology]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[aspirin]]></category>
		<category><![CDATA[esomeprazole]]></category>
		<category><![CDATA[peptic ulcer]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31795</guid>
		<description><![CDATA[NEW YORK (Reuters Health) &#8211; In patients with aspirin-related peptic ulcers, ulcer healing rates are comparable after esomeprazole therapy with or without aspirin continuation, Taiwanese researchers report in an April 17th on-line paper in The American Journal of Gastroenterology. In fact, the investigators suggest that &#8220;continuing low-dose aspirin plus a proton pump inhibitor is the -]]></description>
		
			<media:content duration="1:34" medium="video">
		<media:title><![CDATA[Aspirin use doesn&#8217;t curb peptic ulcer healing]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) &#8211; In patients with aspirin-related peptic ulcers, ulcer healing rates are comparable after esomeprazole therapy with or without aspirin continuation, Taiwanese researchers report in an April 17th on-line paper in The American Journal of Gastroenterology. In fact, the investigators suggest that &#8220;continuing low-dose aspirin plus a proton pump inhibitor is the -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/aspirin-use-doesnt-curb-peptic-ulcer-healing/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120515clin005.jpg"/>
	<media:keywords><![CDATA[aspirin,esomeprazole,peptic ulcer]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>ACE inhibitors tied to increased angioedema risk</title>
		<link>http://www.thedoctorschannel.com/view/ace-inhibitors-tied-to-increased-angioedema-risk/</link>
		<pubDate>Tue, 15 May 2012 18:53:02 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nephrology]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Pharmacists]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[ACE inhibitors]]></category>
		<category><![CDATA[angioedema]]></category>
		<category><![CDATA[angiotensin]]></category>
		<category><![CDATA[ARB]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31793</guid>
		<description><![CDATA[NEW YORK (Reuters Health) &#8211; Pooled data suggest that use of renin–angiotensin system (RAS) inhibitors, particularly angiotensin converting enzyme (ACE) inhibitors may increase the risk of angioedema, researchers report in an April 20th on-line paper in the American Journal of Cardiology. Nevertheless, Dr. Franz H. Messerli told Reuters Health by email, &#8220;ACE inhibitors are among -]]></description>
		
			<media:content duration="1:29" medium="video">
		<media:title><![CDATA[ACE inhibitors tied to increased angioedema risk]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) &#8211; Pooled data suggest that use of renin–angiotensin system (RAS) inhibitors, particularly angiotensin converting enzyme (ACE) inhibitors may increase the risk of angioedema, researchers report in an April 20th on-line paper in the American Journal of Cardiology. Nevertheless, Dr. Franz H. Messerli told Reuters Health by email, &#8220;ACE inhibitors are among -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/ace-inhibitors-tied-to-increased-angioedema-risk/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120515clinc003.jpg"/>
	<media:keywords><![CDATA[ACE inhibitors,angioedema,angiotensin,ARB]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Mefloquine malaria prophylaxis appears safe during pregnancy</title>
		<link>http://www.thedoctorschannel.com/view/mefloquine-malaria-prophylaxis-appears-safe-during-pregnancy-2/</link>
		<pubDate>Mon, 14 May 2012 17:09:43 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Ob/Gyn]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Travel Medicine]]></category>
		<category><![CDATA[malaria]]></category>
		<category><![CDATA[Mefloquine]]></category>
		<category><![CDATA[pregnancy]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31746</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Pregnant women may safely receive mefloquine for malaria prophylaxis, researchers from Switzerland report in the April 10th online Clinical Infectious Diseases. “Women who inadvertently become pregnant while taking mefloquine should be reassured that the risk of malformations is low (within background levels) and that use of mefloquine does not indicate -]]></description>
		
			<media:content duration="1:47" medium="video">
		<media:title><![CDATA[Mefloquine malaria prophylaxis appears safe during pregnancy]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Pregnant women may safely receive mefloquine for malaria prophylaxis, researchers from Switzerland report in the April 10th online Clinical Infectious Diseases. “Women who inadvertently become pregnant while taking mefloquine should be reassured that the risk of malformations is low (within background levels) and that use of mefloquine does not indicate -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/mefloquine-malaria-prophylaxis-appears-safe-during-pregnancy-2/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120514epid0011.jpg"/>
	<media:keywords><![CDATA[malaria,Mefloquine,pregnancy]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Postpartum implants curb adolescent pregnancies</title>
		<link>http://www.thedoctorschannel.com/view/postpartum-implants-curb-adolescent-pregnancies/</link>
		<pubDate>Fri, 11 May 2012 20:50:26 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Ob/Gyn]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[contraceptive]]></category>
		<category><![CDATA[etonogestrel]]></category>
		<category><![CDATA[Teen pregnancy]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31699</guid>
		<description><![CDATA[NEW YORK (Reuters Health) &#8211; Giving adolescent mothers postpartum contraceptive implants is an effective curb on further pregnancies within a year, researchers report in an April 18th on-line paper in the American Journal of Obstetrics and Gynecology.&#8221; &#8220;Initiation of the etonogestrel implant immediately after delivery,&#8221; Dr. Kristina M. Tocce, told Reuters Health by email &#8220;significantly -]]></description>
		
			<media:content duration="1:37" medium="video">
		<media:title><![CDATA[Postpartum implants curb adolescent pregnancies]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) &#8211; Giving adolescent mothers postpartum contraceptive implants is an effective curb on further pregnancies within a year, researchers report in an April 18th on-line paper in the American Journal of Obstetrics and Gynecology.&#8221; &#8220;Initiation of the etonogestrel implant immediately after delivery,&#8221; Dr. Kristina M. Tocce, told Reuters Health by email &#8220;significantly -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/postpartum-implants-curb-adolescent-pregnancies/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120511clin004.jpg"/>
	<media:keywords><![CDATA[contraceptive,etonogestrel,Teen pregnancy]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Higher beta-blocker dose lowers mortality in heart failure patients</title>
		<link>http://www.thedoctorschannel.com/view/higher-beta-blocker-dose-lowers-mortality-in-heart-failure-patients-2/</link>
		<pubDate>Wed, 09 May 2012 21:43:01 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Pharmacists]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[beta-blocker]]></category>
		<category><![CDATA[Heart Failure]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31316</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Confirming recommendations, titrating beta-blocker dosage in ambulatory patients with heart failure up to an equivalent of 50 mg/d carvedilol reduces all-cause deaths and hospitalizations, according to a report in the July 17 issue of the Journal of the American College of Cardiology. “There was no increase in bradycardia with higher -]]></description>
		
			<media:content duration="1:27" medium="video">
		<media:title><![CDATA[Higher beta-blocker dose lowers mortality in heart failure patients]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Confirming recommendations, titrating beta-blocker dosage in ambulatory patients with heart failure up to an equivalent of 50 mg/d carvedilol reduces all-cause deaths and hospitalizations, according to a report in the July 17 issue of the Journal of the American College of Cardiology. “There was no increase in bradycardia with higher -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/higher-beta-blocker-dose-lowers-mortality-in-heart-failure-patients-2/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120509clin001.jpg"/>
	<media:keywords><![CDATA[beta-blocker,Heart Failure]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Metformin may prevent liver cancer in type 2 diabetes</title>
		<link>http://www.thedoctorschannel.com/view/metformin-may-prevent-liver-cancer-in-type-2-diabetes/</link>
		<pubDate>Wed, 09 May 2012 21:35:04 +0000</pubDate> 
				<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[Endocrinology]]></category>
		<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Pharmacists]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[colorectal]]></category>
		<category><![CDATA[diabetes]]></category>
		<category><![CDATA[liver]]></category>
		<category><![CDATA[metformin]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31303</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Metformin appears to lower the risk of developing liver cancer in patients with type 2 diabetes, according to the results of a meta-analysis reported in the July issue of the Journal of Clinical Endocrinology and Metabolism. However, “Further investigation, including mechanistic studies, well-designed cohort studies, and possibly controlled trials, is -]]></description>
		
			<media:content duration="1:22" medium="video">
		<media:title><![CDATA[Metformin may prevent liver cancer in type 2 diabetes]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Metformin appears to lower the risk of developing liver cancer in patients with type 2 diabetes, according to the results of a meta-analysis reported in the July issue of the Journal of Clinical Endocrinology and Metabolism. However, “Further investigation, including mechanistic studies, well-designed cohort studies, and possibly controlled trials, is -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/metformin-may-prevent-liver-cancer-in-type-2-diabetes/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120509clin006.jpg"/>
	<media:keywords><![CDATA[cancer,colorectal,diabetes,liver,metformin]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Growth hormone maintains cognition in children with Prader-Willi syndrome</title>
		<link>http://www.thedoctorschannel.com/view/growth-hormone-maintains-cognition-in-children-with-prader-willi-syndrome-2/</link>
		<pubDate>Tue, 08 May 2012 22:00:35 +0000</pubDate> 
				<category><![CDATA[Endocrinology]]></category>
		<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Medical Students]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[cognition]]></category>
		<category><![CDATA[growth hormone]]></category>
		<category><![CDATA[Prader-Willi]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31256</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – The decline in cognitive function in children with Prader-Willi syndrome can be stabilized with ongoing growth-hormone (GH) therapy, a Dutch team reports in the July issue of the Journal of Clinical Endocrinology and Metabolism. “Furthermore, children with a greater deficit had more benefit from GH treatment,” Dr. Elbrich P. C. -]]></description>
		
			<media:content duration="1:37" medium="video">
		<media:title><![CDATA[Growth hormone maintains cognition in children with Prader-Willi syndrome]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – The decline in cognitive function in children with Prader-Willi syndrome can be stabilized with ongoing growth-hormone (GH) therapy, a Dutch team reports in the July issue of the Journal of Clinical Endocrinology and Metabolism. “Furthermore, children with a greater deficit had more benefit from GH treatment,” Dr. Elbrich P. C. -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/growth-hormone-maintains-cognition-in-children-with-prader-willi-syndrome-2/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120508clin003.jpg"/>
	<media:keywords><![CDATA[cognition,growth hormone,Prader-Willi]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
	</channel>
</rss>
